Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coenzyme Q-binding protein COQ10 homolog B, mitochondrial (COQ10B), is a human protein encoded by the *COQ10B* gene and is a homolog of the yeast Coq10 protein. This protein is believed to bind and possibly chaperone coenzyme Q (ubiquinone/CoQ10) within the mitochondrion, facilitating proper localization and function of CoQ10, a critical cofactor in electron transport and antioxidant defense. COQ10B is part of the START domain- and lipid-transfer protein family, indicating a function in mitochondrial lipid trafficking rather than direct enzyme activity or receptor function. In model organisms, its loss impairs respiratory capacity and increases sensitivity to oxidative stress, highlighting a supportive but non-enzymatic, non-receptor role in cellular energy metabolism and oxidative protection[4]. Mutations in homologous proteins can be linked to mitochondrial dysfunction, but there is no evidence that COQ10B itself is a direct therapeutic target in current pharmacology, nor does it interact with drugs such as coenzyme Q10 supplementation[3][4]. Key clarification: - The target name "coenzyme Q10B" or "COQ10B" does not refer directly to coenzyme Q10 or ubiquinone itself, which *is* a therapeutic target, antioxidant, and metabolic cofactor[1][2][5]. Instead, COQ10B is a protein that may bind and help localize or stabilize coenzyme Q10 in mitochondria. - *COQ10B is not considered a canonical therapeutic target* such as an enzyme or receptor, but rather a mitochondrial lipid-binding/chaperone protein. The actual clinical interest and targeting is focused on coenzyme Q10 (ubiquinone), not on the COQ10B protein. Reasons for "is_incorrect: true": - The submitted target is frequently confused with "coenzyme Q10" (ubiquinone, a drug/target), but "COQ10B" is a mitochondrial protein/chaperone and not itself a pharmacological target or therapeutic receptor/enzyme/transporter[4]. - There is no evidence for direct drug targeting, known clinical drugs, or mechanisms of action for COQ10B itself. Distinction: - For structured data regarding mitochondrial coenzyme Q10 as a therapeutic target, see entries for "Coenzyme Q10" or "Ubiquinone".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coenzyme Q-binding protein COQ10 homolog B, mitochondrial (COQ10B).